Clinical Impact of [18F]FDG-PET in Patients with Suspected Recurrent Breast Cancer Based on Asymptomatically Elevated Tumor Marker Serum Levels: a Preliminary Report
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.